Product Reports Resources Pricing Login Book a demo

Flatiron Health

Biotech & Life Sciences · New York City, United States · Founded 2012

Oncology real-world data and evidence generation platform

Investors

20 investors on Flatiron Health's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 17 investors entered at this stage
Series B+ 3 investors entered at this stage
Allen & Company
Roche Venture Fund
Roche

Global footprint

Where Flatiron Health has talent and traffic

Workforce by country
10 countries with
team presence
🇺🇸 United States92.2%
🇬🇧 United Kingdom3.4%
🇩🇪 Germany2.2%
🇯🇵 Japan1.4%
🇮🇳 India0.2%
Top 5 of 10 shown
Web traffic by country
660K monthly visits
across markets
🇺🇸 United States92.6%
🇬🇧 United Kingdom1.7%
🏳️ Puerto Rico1.2%
🇨🇦 Canada0.9%
🇵🇭 Philippines0.5%
Top 5 markets shown

Talent graph

The shape of Flatiron Health's talent

Dealroom maps Flatiron Health's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

20 standout operatorsDealroom-flagged across the org
56 AI specialistsincl. 13 core researchers
1,451 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Flatiron Health's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$8M patent portfolio · 33 active families

Estimated portfolio value
$8M
0.44% of valuation · 2.9× smaller than top peer Lunit ($24M)
33 active patent families
Where Flatiron Health innovates Data libraryData miningData scienceData setGraphical user interface

Where Flatiron Health concentrates vs peers

Each axis is a top-10 topic across Flatiron Health and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Flatiron Health's 6 investments and acquisitions.

Every disclosed deal where Flatiron Health appeared as a backer or acquirer, 2018–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across Flatiron Health's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Flatiron Health's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        What the market is saying about Flatiron Health

        An AI-synthesized read of the highest-engagement posts about Flatiron Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Flatiron Health on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.